Finance News Network

Company Presentations

Rural Funds Group (ASX:RFF) Full Year FY18 Results Presentation

20 Aug 2018 - Rural Funds Group Limited (ASX:RFF) Managing Director David Bryant presents the company's full year FY18 results.

Centuria Capital Group (ASX:CNI): FY18 Results Presentation

14 Aug 2018 - Centuria Capital Group Limited (ASX:CNI) Group CEO, John McBain, presents the company's FY18 results.

BrainChip Holdings (ASX:BRN) June 2018 Quarter Update

02 Aug 2018 - BrainChip Holdings Limited (ASX:BRN) CEO, Louis DiNardo, provides a June 2018 Quarter Update covering the Akida Development Environment, BrainChip Studio and the Veri…

Credit Corp Group (ASX:CCP): FY18 Results Presentation

31 July 2018 - Credit Corp Group Limited (ASX:CCP) CEO, Thomas Beregi presents the company's FY18 results.

Vault Intelligence (ASX:VLT) Presentation, FNN Investor Event, June 2018, Sydney

27 Jun 2018 - Vault Intelligence Limited (ASX:VLT) Director, Robert Kirtlan presents on Vault's industry-leading safety technology, global customers and product suite.

Medibio (ASX:MEB) Presentation, FNN Investor Event, June 2018, Sydney

27 Jun 2018 - Medibio Limited (ASX:MEB) Senior Vice President, Corporate Health, Peta Slocombe discusses the company's suite of measurement tools, which acquire biometrics that cor…

Novonix (ASX:NVX) Presentation, FNN Investor Event, June 2018, Sydney

26 Jun 2018 - Novonix Limited (ASX:NVX) Managing Director, Philip St Baker presents on the company's lithium-ion battery technology, advanced battery materials business, testing eq…

Image Resources NL (ASX:IMA) Presentation, FNN Investor Event, June 2018, Sydney

25 Jun 2018 - Image Resources NL Limited (ASX:IMA) Managing Director, Patrick Mutz discusses the company's Boonanarring mineral sands project, financing, construction and offtake a…

Carbonxt Group (ASX:CG1) Presentation, FNN Investor Event, June 2018, Sydney

22 Jun 2018 - Carbonxt Group Limited (ASX:CG1) Managing Director, Warren Murphy presents on the company's activated carbon-based solutions for the removal of mercury to help coal-f…

MGM Wireless (ASX:MWR) Presentation, FNN Investor Event, June 2018, Sydney

15 Jun 2018 - MGM Wireless Limited (ASX:MWR) CEO, Mark Fortunatow presents on the company's world-first SPACETALK two-way 3G communication and GPS tracking smartwatch, its expansio…

Alcidion Group (ASX:ALC) Presentation, FNN Investor Event, June 2018, Sydney

15 Jun 2018 - Alcidion Group Limited (ASX:ALC) CEO and Director, Ray Blight presents on the company's recent acquisitions and how this will deliver scale, international customers a…

Recce Pharmaceuticals (ASX:RCE) Presentation, FNN Investor Event, June 2018, Sydney

14 Jun 2018 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham presents on the company's lead product RECCE 327 for use in targeting antibiotic-resistant ba…

1st Group (ASX:1ST) Presentation, FNN Investor Event, June 2018, Sydney

13 Jun 2018 - 1st Group Limited (ASX:1ST) Managing Director, CEO and Co-Founder, Klaus Bartosch presents the company's portfolio of convenient and secure booking and online interac…

Volpara Health Technologies (ASX:VHT) Presentation, FNN Investor Event, June 2018, Sydney

12 Jun 2018 - Volpara Health Technologies Limited (ASX:VHT) CEO, Dr Ralph Highnam presents on the rollout of the company's software in the US and how it is improving breast cancer …

First Graphene (ASX:FGR) Presentation, FNN Investor Event, May 2018, Sydney

31 May 2018 - First Graphene Limited (ASX:FGR) Non-Executive Chairman, Warwick Grigor, talks applications from smart concrete, fire retardants, batteries and growing the market for…

Nuheara (ASX:NUH) Presentation, FNN Investor Event, May 2018, Sydney

01 Jun 2018 - Nuheara Limited (ASX:NUH) Co-founder & CEO, Justin Miller, presents on the success of IQbuds and the launch of the company's second generation IQbuds BOOST for people…

Immutep (ASX:IMM) Presentation, Clinical Results of Ongoing Melanoma Study and Update on Eftilagimod Alpha Clinical Development Strategy, May 2018

31 May 2018 - Immutep Limited (ASX:IMM) CEO, Marc Voigt, CSO & CMO, Dr Frederic Triebel and Director Clinical Development, Christian Mueller present on clinical results of the comp…